UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 693

Sortiert nach

Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy

European journal of cancer (1990), 2012-06, Vol.48 (9), p.1318-1325

2012

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway

Oncogene, 2016-09, Vol.35 (37), p.4914-4926

2016

Link zum Volltext

Verfügbarkeit prüfen

BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts

British journal of cancer, 2015-07, Vol.113 (3), p.425-432

2015

Link zum Volltext

Verfügbarkeit prüfen

Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity

Cancer chemotherapy and pharmacology, 2017-05, Vol.79 (5), p.959-969

2017

Link zum Volltext

Verfügbarkeit prüfen

An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy

British journal of radiology, 2014-03, Vol.87 (1035), p.20130753-20130753

2014

Link zum Volltext

Verfügbarkeit prüfen

HDAC inhibitor confers radiosensitivity to prostate stem-like cells

British journal of cancer, 2013-12, Vol.109 (12), p.3023-3033

2013

Link zum Volltext

Verfügbarkeit prüfen

Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response

British journal of cancer, 2012-08, Vol.107 (5), p.840-846

2012

Link zum Volltext

Verfügbarkeit prüfen

Intermediate Risk Prostate Cancer: Disease Heterogeneity Linked to Measurable Biological Features

Clinical oncology (Royal College of Radiologists (Great Britain)), 2020-05, Vol.32 (5), p.298-302

2020

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity

Cancer chemotherapy and pharmacology, 2024-01

2024

Link zum Volltext

Verfügbarkeit prüfen

Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy

ESMO open, 2023-04, Vol.8 (2), p.101194-101194, Article 101194

2023

Link zum Volltext

Verfügbarkeit prüfen

Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies

Molecular oncology, 2016-05, Vol.10 (5), p.645-651

2016

Link zum Volltext

Verfügbarkeit prüfen

Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: A good thing?

Cancer treatment reviews, 2010-05, Vol.36 (3), p.230-234

2010

Link zum Volltext

Verfügbarkeit prüfen

IDH mutation status in prostate cancer

Oncogene, 2012-08, Vol.31 (33), p.3826-3826

2012

Link zum Volltext

Verfügbarkeit prüfen

T1/T2 Glottic Cancer Managed by External Beam Radiotherapy: The Influence of Pretreatment Hemoglobin on Local Control

International journal of radiation oncology, biology, physics, 1998-05, Vol.41 (2), p.347-353

1998

Link zum Volltext

Verfügbarkeit prüfen

Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer: author reply

British journal of radiology, 2015-01, Vol.88 (1045), p.20140701-20140701

2015

Link zum Volltext

Verfügbarkeit prüfen

Locally Advanced Prostate Cancer: Current Controversies and Optimisation Opportunities

Clinical oncology (Royal College of Radiologists (Great Britain)), 2013-08, Vol.25 (8), p.499-505

2013

Link zum Volltext

Verfügbarkeit prüfen

Chk2 Is a Tumor Suppressor That Regulates Apoptosis in both an Ataxia Telangiectasia Mutated (ATM)-Dependent and an ATM-Independent Manner

Molecular and Cellular Biology, 2002-09, Vol.22 (18), p.6521-6532

2002

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy

Bladder cancer, 2016-01, Vol.2 (1), p.101-109

2016

Link zum Volltext

Verfügbarkeit prüfen

Mutator phenotype in Msh2-deficient murine embryonic fibroblasts

Cancer research (Chicago, Ill.), 1997-09, Vol.57 (17), p.3765-3771

1997

Link zum Volltext

Verfügbarkeit prüfen

Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation

Oncogene, 1998-04, Vol.16 (14), p.1789-1802

1998

Link zum Volltext

Verfügbarkeit prüfen

Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras

Oncogene, 1994-06, Vol.9 (6), p.1527-1536

1994

Link zum Volltext

Verfügbarkeit prüfen

Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines II: in vivo radioresponse following fractionated treatment and in vitro/in vivo correlations

International journal of radiation oncology, biology, physics, 1990-02, Vol.18 (2), p.331-345

1990

Link zum Volltext

Verfügbarkeit prüfen

The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy

Radiotherapy and Oncology, 1996-09, Vol.40 (3), p.197-223

1996

Link zum Volltext

Verfügbarkeit prüfen

Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill

Prostate cancer and prostatic diseases, 2003-03, Vol.6 (1), p.73-85

2003

Link zum Volltext

Verfügbarkeit prüfen

Post-operative radiotherapy for recurrent dermoid cysts of the spine : a report of 3 cases

Journal of neuro-oncology, 1997-07, Vol.33 (3), p.251-256

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 693

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(633)
Mit Volltextzugriff
(599)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(430)
Life Sciences & Biomedicine
(336)
Humans
(287)
Male
(165)
Biological And Medical Sciences
(155)
Female
(132)
Medical Sciences
(119)
Middle Aged
(95)
Oncology
(87)
Animals
(84)
Cardiac & Cardiovascular Systems
(83)
Cardiovascular System & Cardiology
(83)
Physical Sciences
(75)
Adult
(66)
Pharmacology. Drug Treatments
(57)
Aged
(47)
Surgery
(47)
Mice
(42)
Fundamental And Applied Biological Sciences. Psychology
(39)
Heart Transplantation
(39)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy

Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway

BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts

Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity

An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy

HDAC inhibitor confers radiosensitivity to prostate stem-like cells

Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response

Intermediate Risk Prostate Cancer: Disease Heterogeneity Linked to Measurable Biological Features

Correction to: Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity

Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy

Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies

Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: A good thing?

IDH mutation status in prostate cancer

T1/T2 Glottic Cancer Managed by External Beam Radiotherapy: The Influence of Pretreatment Hemoglobin on Local Control

Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer: author reply

Locally Advanced Prostate Cancer: Current Controversies and Optimisation Opportunities

Chk2 Is a Tumor Suppressor That Regulates Apoptosis in both an Ataxia Telangiectasia Mutated (ATM)-Dependent and an ATM-Independent Manner

Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy

Mutator phenotype in Msh2-deficient murine embryonic fibroblasts

Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation

Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras

Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines II: in vivo radioresponse following fractionated treatment and in vitro/in vivo correlations

The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy

Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill

Post-operative radiotherapy for recurrent dermoid cysts of the spine : a report of 3 cases

Suchergebnisse filtern